Navigation Links
WaveSense Reduces Diabetes Testing Cost by 50%
Date:6/4/2009

SALEM, N.H., June 4 /PRNewswire/ -- The makers of the WaveSense(TM) line of blood glucose monitoring products (AgaMatrix, Inc.) announced today their continued commitment to providing low cost, high accuracy, and high quality blood glucose monitoring (BGM) products for people with diabetes. The WaveSense Presto(TM) BGM can be found at leading retailers nationwide, including Wal-Mart(R) and Kroger(R). Presto test strips (50 ct) are often as low as $22.88, less than half the typical price of strips from major brands.

The high cost of testing supplies can cause financial hardship for people with diabetes who do not have complete health insurance coverage or who do not have insurance. Often times products that sell at lower prices are not high accuracy or high quality, do not have a proven track record of meter and strip placement in the market, and are not readily available to consumers. WaveSense products feature a new technology that makes testing accurate and affordable and they are used by hundreds of thousands of patients worldwide.

"WaveSense provides the LSU Health Care Services Division outpatient pharmacies the means to provide a high quality, affordable blood glucose monitoring system to our patient population," said Danny Jackson, System Director of Pharmacy for the LSU Health Care Services Division. "The no coding feature and the benefits of WaveSense accuracy deliver a premium, easy-to-use system to the market at a price point that makes testing possible for those patients with limited or no health insurance."

Affordable BGM testing has become increasingly important given today's economic environment. Furthermore, the number of people with diabetes is growing each year, causing both public and private health insurance to spend even more money treating the disease. Marian Batts-Turner, a leading certified diabetes educator (CDE) and member of the American Association of Diabetes Educators (AADE) Board of Directors said, "There is indisputable evidence that better glycemic control decreases the risk of complications in people with diabetes, such as cardiovascular disease and kidney failure. WaveSense technology uniquely enables affordable systems for patients to monitor their blood sugar accurately and reliably."

For more information on WaveSense products, go to: http://www.wavesense.info.

About WaveSense:

WaveSense(TM) is a line of blood glucose meters and strips designed to improve the quality of diabetes care by using a new technology that personalizes each test to provide world class accuracy. It detects and corrects for many errors caused by differences in blood samples and environmental conditions. Current products include the WaveSense KeyNote(TM), WaveSense KeyNote Pro(TM), WaveSense Presto(TM), WaveSense Jazz(TM), and Zero-Click(TM), a diabetes data management system designed to simplify data download.

(C) 2002-2009 AgaMatrix, Inc. WaveSense; Presto; Pro; KeyNote; WaveSense Jazz; and Zero-Click are trademarks of AgaMatrix, Inc. Wal-Mart and Kroger are registered trademarks of their respective owners.


'/>"/>
SOURCE AgaMatrix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New WaveSense Presto(TM) and Pro(TM) Glucose Meters to Simplify Testing
2. Ex-Head of Menarini Diabetes Unit Launches WaveSense Europe
3. Text Messaging Medication Reminders Significantly Reduces Organ Rejection in Pediatric Liver Transplant Recipients
4. Intervention reduces delinquent teenage pregancy rates
5. New blood test greatly reduces false-positives in prostate cancer screening
6. Mayo study finds that team preop briefing improves communication, reduces errors
7. Mayo Study Finds That Team Preop Briefing Improves Communication, Reduces Errors
8. BioRays CytoFlora Reduces Digestive and Behavioral Issues in Autistic Children
9. Folic Acid Reduces Infant Heart Defects
10. 3-Drug Combo Reduces Nausea After Chemo
11. Dr. Elliot Jacobs' New 'Hypo Lipo' Procedure Permanently Reduces Hyperhidrosis and Body Odor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical group ... serving as new board chair for Orange County health care system CalOptima Friday. ... of soon-to-be former chair Mark Refowitz’s term, which runs through June 30 of ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... measurement of corrosive ions found in power plant water and steam. , Chlorides ... as turbines and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ...
(Date:3/28/2017)... ... 2017 , ... A minimally invasive porcelain veneer is increasing ... Association of Dental Laboratories (NADL) is informing dentists about the benefits of minimally ... dental laboratories and technicians that create these veneers. , According to National ...
(Date:3/28/2017)... Atlantic City, NJ (PRWEB) , ... March 28, ... ... annual American Camp Association’s Tri-State Camp Conference in Atlantic City March 13-16, was ... partners, and their team of professional staff discussed strategies for preventing outbreaks among ...
(Date:3/28/2017)... ... ... Thank you to all who attended Capio Partners Winter 2017 Healthcare Leadership Symposium ... providers and offered an opportunity to collaborate and network with healthcare colleagues across the ... attendees gathered for a lively discussion on trends and issues that healthcare leaders will ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Medtec Europe will once ... 600 exhibitors from 70 countries the opportunity to ... will advance the medical technology industry. Taking place ... Stuttgart, Stuttgart, Germany , Medtec ... the key trends and insights across the entire ...
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, ... by Ethicon, a division of Johnson & Johnson. Torax ... for the treatment of gastro-esophageal reflux disease (GERD). ... augmentation (MSA) technology and the procedure is currently ... Torax Medical was founded by Sanderling ...
(Date:3/27/2017)... SAN DIEGO and VANCOUVER, British Columbia, March 27, ... SPHS ) (the "Company" or "Sophiris"), a clinical ... treatment of patients with urological diseases, today reported ... and key corporate highlights. Key ... in Clinical Development for Localized Prostate Cancer. During ...
Breaking Medicine Technology: